Dicyclomine hydrochloride NDC 68071-5298

NDC codes

FDA NDC Directory

Product NDC (as listed)68071-5298Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68071-5298Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68071-5298-3	68071529803	30 TABLET in 1 BOTTLE (68071-5298-3)Marketed from Jun 10, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dicyclomine hydrochloride
Generic name (nonproprietary): dicyclomine hydrochloride
Active ingredients: Dicyclomine hydrochloride — 20 mg/1
Dosage form: Tablet
Route: Oral
Labeler: NuCare Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218952
Marketing start: Nov 15, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Cholinergic Antagonists (Mechanism)
Identifiers: Product ID 68071-5298_53e88b6b-5245-b38e-e063-6394a90a1d10SPL ID 53e88b6b-5245-b38e-e063-6394a90a1d10SPL set ID 53e8777d-d54f-a9da-e063-6294a90a1608RxCUI 991086UNII CQ903KQA31UPC 0368071529838
Pharmacologic class: Anticholinergic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468071529803 followed by a unit qualifier and the quantity

Package 68071-5298-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 10, 2026.

Indications (excerpt from the label)

Dicyclomine hydrochloride tablets are indicated for the treatment of patients with functional bowel/irritable bowel syndrome. Dicyclomine hydrochloride tablets are an antispasmodic and anticholinergic (antimuscarinic) agent indicated for the treatment of functional bowel/irritable bowel syndrome ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 218952

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218952
Product	Strength	Form · route	Labeler	Product NDC
Dicyclomine hydrochloride	Dicyclomine hydrochloride 20 mg/1	TabletOral	Rising Pharma Holdings, Inc.	16571-259